Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CORV - Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH CORV


CORV - Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH CORV

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH, CORV

NEW YORK, NY / ACCESSWIRE / March 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

The investigation concerns whether Tetraphase and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Tetraphase to AcelRx Pharmaceuticals, Inc. for 0.6303 shares of AcelRx for each share of Tetraphase. If you are a Tetraphase shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/tetraphase-pharmaceuticals-inc-ttph-stock-merger-acelrx/.

Correvio Pharma Corp. (NASDAQ:CORV)

The investigation concerns whether Correvio and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Correvio to ADVANZ PHARMA Corp. Limited for $0.42 per share. If you are a Correvio shareholder and would like to learn more about your legal rights and options, please visit https://halpersadeh.com/actions/correvio-pharma-corp-corv-stock-merger-advanz/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

CONTACT:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/580980/Are-Shareholders-Getting-a-Fair-Deal-Halper-Sadeh-LLP-Investigates-the-Sale-of-These-Companies--TTPH-CORV

Stock Information

Company Name: Correvio Pharma Corp.
Stock Symbol: CORV
Market: NASDAQ
Website: correvio.com

Menu

CORV CORV Quote CORV Short CORV News CORV Articles CORV Message Board
Get CORV Alerts

News, Short Squeeze, Breakout and More Instantly...